Medizinische Universität Graz - Research portal
Stöger Herbert |
Presentations at scientific and public conferences
Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stöger, H; Leithner, A; Heitzer, E; Liegl, B; Szkandera, J
Die molekularpathologische Testung von Weichteilsarkomen mittels FoundationOne® Heme bestätigt potentielle therapeutische Targets: Ergebnisse einer monozentrischen Analyse
Abstractband 1. Österreichischer Kongress für Orthopädie & Traumatologie. 2022; -1. Österreichischer Kongress für Orthopädie & Traumatologie; 12.-14. Mai, 2022; Graz, Austria.
[Poster]
Barth, DA; Brenner, C; Riedl, JM;Prinz, F; Klocker, EV; Schlick, K; Kornprat, P; Lackner, K; Stöger, H; Stotz, M;Gerger, A; Pichler, M
External validation of the prognostic relevance of the Advanced Lung Cancer Infammation Index (ALI) in pancreatic cancer patients
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology 2020. 2020; 13 (Suppl 2): 23-65.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; MAR 19-21, 2020; Vienna, AUSTRIA.
[Poster]
Gerger, A; Riedl, JM; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E
Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial.
ANN ONCOL. 2020; 31: S1095-S1096.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.08.1331
[Onlinepräsentation]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Klec, C; Kapeller, A; Prinz, F; Trenk, C; Stoger, H; Pichler, M
Dissecting the interplay of the long non-coding RNA NORAD and PARP inhibitors in triple negative breast cancer.
CANCER RES. 2020; 80(4):-San Antonio Breast Cancer Symposium; DEC 10-14, 2019; San Antonio, TX.
Doi: 10.1158/1538-7445.SABCS19-P1-05-13
[Poster]
Web of Science
FullText
FullText_MUG
Klec, C; Schwarzenbacher, D; Gottschalk, B; Margit, R; Prinz, F; Bauernhofer, T; Stoeger, H; Graier, WF; Pichler, M
Deciphering the interplay between nuclear RNA export factors and long non-coding RNAs in breast cancer metabolism.
ANN ONCOL. ESMO Breast Cancer Virtual Meeting 2020. 2020; 31(S2):S38-S38.-ESMO Breast Cancer Virtual Meeting; MAY 23-24, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.03.202
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Posch, F; Barth, D; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Riedl, JM
C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: A bi-center study.
ANN ONCOL. 2020; 31: S286-S286.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.08.234
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Riedl, J; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E; Gerger, A
Individualized cancer treatment based on molecular profiling of circulating tumor DNA in patients with advanced and refractory carcinoma: a prospective phase II trial.
ONCOL RES TREAT. 2020; 43(SUPPL 4):249-249.-DGHO Jahrestagung; 09.10. -11.10.2020; Basel (virtueller Kongress).
[Oral Communication]
Web of Science
Riedl, J; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Schaberl-Moser, R; Stotz, M; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A
FOLFIRINOX versus Gemcitabine/nab-Paclitaxel as palliative first-line treatment of advanced pancreatic cancer: An Austrian observational Tri-Center comparative effectiveness analysis.
ONCOL RES TREAT. 2020; 43(SUPPL 4):215-215.
[Poster]
Web of Science
Riedl, JM; Posch, F; Gantschnigg, A; Horvath, L; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A
FOLFIRINOX versus Gemcitabine/nabPaclitaxel as First-line palliative Therapy in advanced Pancreatic Cancer: a Propensity-Score Analysis.
WIEN KLIN WOCHENSCHR. Abstracts 51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):78-79.-51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA.
[Poster]
Web of Science
Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A
Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
ANN ONCOL. 2020; 31: S942-S942.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.08.2013
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Schwarzenbacher, E; Moik, F; Horvath, L; Renneberg, F; Posch, F; Barth, D; Gantschnigg, A; Schaberl-Moser, R; Pichler, M; Stotz, M; Stoger, H; Ay, C; Greil, R; Gerger, A; Djanani, A; Schlick, K; Riedl, J
Incidence, prediction and outcome of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of Gemcitabine/nab-Paclitxel or FOLFIRINOX.
ONCOL RES TREAT. 2020; 43(SUPPL 4):214-214.
[Poster]
Web of Science
Schwarzenbacher, E; Moik, F; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Ay, C; Stoger, H; Greil, R; Djanani, A; Gerger, A; Schlick, K; Riedl, JM
Patterns of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of gemcitabine/nab-paclitxel or FOLFIRINOX.
ANN ONCOL. 2020; 31: S949-S950.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.08.2035
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Suppan, C; Steiner, D; Klocker, VE; Posch, F; Henzinger, EC; Stoeger, H; Dandachi, N; Balic, M
Safety and clinical evaluation of dual inhibition with pertuzumab and trastuzumab in HER-2-positive breast cancer patients.
J CLIN ONCOL. 2020; 38(15):
[Onlinepräsentation]
Web of Science
FullText
Aziz, F; Stelzl, A; Riedl, J; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H
Diabetes is a predictor for survival in soft tissue sarcoma patients
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S477-S477.
[Poster]
Web of Science
Aziz, F; Stelzl, A; Riedl, JM; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H
Association of serum glucose levels with disease free survival in soft tissue sarcoma patients
DIABETOLOGIA. 2019; 62: S562-S563.-55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 16-20, 2019; Barcelona, SPAIN.
[Poster]
Web of Science
Barth, D; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Gerger, A; Stotz, M
Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Proceedings of the Annual Meeting of the Austrian Society
of Haematology and Medical Oncology. 2019; -OeGHO Frühjahrstagung 2019; APR 11-13; Linz, AUSTRIA.
[Poster]
Barth, DA; Riedl, JM; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A
External validation and longitudinal extension of the LIPI (lung immune prognostic index) for immunotherapy outcomes in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 108-108.
[Poster]
Web of Science
Fastner, G; Sedlmayer, F; Widder, J; Metz, M; Geinitz, H; Kapp, K; Solkner, L; Greil, R; Jakesz, R; Kwasny, W; Heck, D; Bjelic-Radisic, V; Balic, M; Stoger, H; Wieder, U; Zwrtek, R; Semmler, D; Horvath, W; Melbinger-Zeinitzer, E; Wiesholzer, M; Wette, V; Gnant, M
Antihormones with or without irradiation in breast cancer: 10-year results of the ABCSG 8A trial
RADIOTHER ONCOL. 2019; 133: S132-S133.-38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO); APR 26-30, 2019; Milan, ITALY.
Doi: 10.1016/S0167-8140(19)30690-5
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Glantschnig, T; Posch, F; Firla, S; Moik, F; Ablasser, K; Binder, JS; Stoschitzky, G; Wallner, M; Von Lewinski, D; Stoger, H; Zirlik, A; Pichler, M; Rainer, PP
Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
WIEN KLIN WOCHENSCHR. 2019; 131: 292-293.
[Poster]
Web of Science
Klec, C; Kapeller, A; Prinz, F; Trenk, C; Stoeger, H; Pichler, M
Dissecting the interplay of the long non-coding RNA NORAD and PARP inhibitors in triple negative breast cancer.
San Antonio Breast Cancer Symposium. 2019; -SABCS; DEC 10-14; San Antonio, TX, USA.
[Poster]
Klec, C; Schwarzenbacher, D; Gottschalk, B; Resel, M; Prinz, F; Heitzer, E; Bauernhofer, T; Stöger, H; Graier, WF; Pichler, M
Paraspeckle-associated protein 1 (PAP1) controls breast cancer growth by regulating and interacting with the long non-coding RNA NEAT1
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung 2019; 11.-13.April; Linz, AUSTRIA.
[Poster]
Klec, C; Schwarzenbacher, D; Resel, M; Rinner, B; Haybaeck, J; Höfler, G; Jahn, SW; Bauernhofer, T; Stöger, H; Pichler, M
miR-1287-5p inhibits triple negative breast cancer growth by interacting with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung; 11.-13.April; Linz, AUSTRIA.
[Poster]
Klec, C; Schwarzenbacher, D; Resel, M; Rinner, B; Haybaeck, J; Höfler, G; Jahn, SW; Bauernhofer, T; Stöger, H; Pichler, M
miR-1287-5p inhibits triple negative breast cancer growth by interacting with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung 2019; 11.-13.April; Linz, AUSTRIA.
[Oral Communication]
Posch, F; Glantschnig, T; Firla, S; Smolle, M; Balic, M; Moik, F; Stoeger, H; Zirlik, A; Pichler, M; Rainer, P
Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
EUR HEART J. 2019; 40: 3844-3844.-ESC Congress / World Congress of Cardiology; AUG 31-SEP 04, 2019; Paris, FRANCE.
[Poster]
Web of Science
Prinz, F; Reicher, A; Kiesslich, T; Klec, C; Gerger, A; Stoeger, H; Posch, F; Pichler, M
The influence of epithelial-mesenchymal transition on immune checkpoint molecules in biliary tract cancer
OEGHO- & AHOP-Frühjahrstagung 2019; 11.-13.April 2019; Linz, AUSTRIA. 2019.
[Poster]
Prinz, F; Reicher, A; Kiesslich, T; Klec, C; Gerger, A; Stoeger, H; Posch, F; Pichler, M
Influence of epithelial-mesenchymal transition on immune checkpoints in biliary tract cancer
Doctoral Day of the Medical University Graz. 2019; -Doctoral Day of the Medical University Graz; NOV 21, 2019; Graz, AUSTRIA.
[Poster]
Reicher, A; Prinz, F; Klec, C; Stoeger, H; Moik, F; Posch, F; Pichler, M
Characterization of the fundamental role of fibroblast growth factor receptor 2 (FGFR2) gene fusions in carcinogenesis of intrahepatic cholangiocarcinoma using CRISPR/Cas9 genome engineering.
OEGHO- & AHOP-Frühjahrstagung 2019. 2019; -OeGHO- & AHOP-Frühjahrstagung 2019; 11.-13.April, 2019; Linz, AUSTRIA.
[Poster]
Riedl, JM; Barth, D; Posch, F; Foris, V; Absenger, G; Mollnar, S; Pichler, M; Stotz, M; Stoger, H; Olschewski, H; Gerger, A
Longitudinal C-reactive protein (CRP) trajectories predict immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 115-115.
[Poster]
Web of Science
Riedl, JM; Barth, DA; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A
External validation and longitudinal extension of the LIPI (Lung Immune Prognostic Index) for immunotherapy outcomes in advanced non-small cell lung cancer
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN.
[Poster]
Web of Science
Riedl, JM; Stelzl, A; Aziz, F; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stöger, H; Liegl-Atzwanger, B; Stotz,M; Gerger, A; Sourij, H; Szkandera, J
Elevated mean glucose level predicts decreased disease free survival in soft tissue sarcoma patients.
OeGHO- & AHOP-Frühjahrstagung 2019; 11.04.2019 - 13.04.2019; Linz, Austria. 2019.
[Oral Communication]
Scheipner, L; Smolle, MA; Barth, D; Posch, F; Stotz, M; Pichler, M; Stöger, H; Gerger, A; Riedl, JM
The AST/ALT ratio (de ritis) is an independent prognostic marker for disease free survival in stage II and III colorectal cancer
OeGHO- & AHOP-Frühjahrstagung 2019; 11.04.2019 - 13.04.2019; Linz, AUSTRIA. 2019.
[Oral Communication]
Smolle, MA; van de Sande, M; Callegaro, D; Wunder, J; Hayes, AJ; Leitner, L; Bergovec, M; Tunn, PU; van Praag, VM; Panotopoulos, J; Willegger, M; Windhager, R; Riedl, JM; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Leithner, A; Gronchi, A; Haas, RL; Szkandera, J
Advancing soft-tissue sarcoma aftercare using flexible parametric survival models.
Abstract Book of the 32. Annual Meeting of the European Musculoskeletal Tumour Society (EMSOS). 2019; -32. Annual Meeting of the European Musculoskeletal Tumour Society (EMSOS); MAY 15-17, 2019; Florence, ITALY.
[Oral Communication]
Smolle, MA; van de Sande, M; Callegaro, D; Wunder, J; Hayes, AJ; Leitner, L; Bergovec, M; Tunn, PU; van Praag, VM; Panotopoulos, J; Willegger, M; Windhager, R; Riedl, JM; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Leithner, A; Gronchi, A; Haas, RL; Szkandera, J
Individualising soft tissue sarcoma aftercare with flexible parametric survival modelling.
Webabstracts of the 20th General Meeting of the International Society of Limb Salvage (ISOLS). 2019; -20th General Meeting of the International Society of Limb Salvage (ISOLS); SEP 11-14, 2019; Athens, GREECE.
[Oral Communication]
Steger, G; Galid, A; Rechberger, E; Eisterer, W; Herz, W; Petru, E; Pasterk, C; Girschikofsky, M; Singer, C; Grunberger, B; Stoger, H; Marhold, M; Hitzl, D; Lindegger, N
Exploring real world data treatment patterns and outcomes in participants with HER2+unresectable LA/mBC - Austrian participation in the prospective European registry SAMANTHA study
ONCOL RES TREAT. 2019; 42: 41-42.
Web of Science
Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Niedersuss-Beke, D; Tinchon, C; Loidl, W; Pichler, M; Jahn, S; Stoger, H; Bauernhofer, T;
Lymphopenia impairs response to 1st-line tyrosine kinase inhibitor therapy in patients with metastatic clear-cell renal cell carcinoma and modulates the relative efficacy of sunitinib and pazopanib
WIEN KLIN WOCHENSCHR. 2019; 131: S447-S447.-Frühjahrstagung der OeGHO; APR 11-13, 2019; Linz, AUSTRIA.
[Poster]
Web of Science
FullText
Terzic, J; Tinchon, C; Stoger, H
Smoker's Cough - what's behind it?
WIEN KLIN WOCHENSCHR. 2019; 131: S434-S435.
[Oral Communication]
Web of Science
Trenk, C; Prinz, F; Resel, M; Stoeger, H; Klec, C; Pichler, M
miR-4520s as potential regulator of breast carcinogenesis
Doctoral Day 2019. 2019; -Doctoral Day 2019, Medical University of Graz; NOV 21, 2019; Graz, AUSTRIA.
[Poster]
Andritsch, E; Farkas, C; Zloklikovits, S; Gerger, A; Stoger, H
Meaning of personalized medicine and targeted medical therapies for patients with cancer in the context of expectations and hope
ONCOL RES TREAT. 2018; 41: 34-34.
[Oral Communication]
Web of Science
Balic, M; Mueller, DH; Hammer, R; Gumpoldsberger, M; Suppan, C; Posch, F; Stoeger, H; Dandachi, N; Prein, K; Hauser, H; Lax, S
Independent evaluation of prognostic value of residual cancer burden (RCB) score on disease free and overall survival of breast cancer patients treated with neoadjuvant systemic treatment at a single institution
CANCER RES. 2018; 78(4):-San Antonio Breast Cancer Symposium; DEC 05-09, 2017; San Antonio, TX.
[Poster]
Web of Science
Dubsky, PC; Fesl, C; Singer, CF; Pfeiler, G; Kronenwett, R; Hubalek, M; Bartsch, R; Stoeger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Tea, MKM; Wette, V; Petzner, AL; Sevelda, P; Egle, D; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Lax, S; Regitnig, P; Gnant, M; Filipits, M
The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2-breast cancer patients from ABCSG 34
CANCER RES. 2018; 78(4):-San Antonio Breast Cancer Symposium; DEC 05-09, 2017; San Antonio, TX.
[Oral Communication]
Web of Science
Gnant, M; Steger, G; Greil, R; Fitzal, F; Mlineritsch, B; Manfreda, D; Tausch, C; Balic, M; Dubsky, P; Moik, M; Thaler, J; Egle, D; Bjelic-Radisic, V; Selim, U; Exner, R; Singer, C; Melbinger-Zeinitzer, E; Haslbauer, F; Stoger, H; Helfgott, R; Sevelda, P; Trapl, H; Wette, V; Solkner, L; Jakesz, R
A prospective randomized multi-center phase-III trial of additional 2 versus additional 5 years of anastrozole after initial 5 years of adjuvant endocrine therapy - results from 3,484 postmenopausal women in the ABCSG-16 trial
CANCER RES. 2018; 78(4):-San Antonio Breast Cancer Symposium; DEC 05-09, 2017; San Antonio, TX.
[Oral Communication]
Web of Science
Klec, C; Resel, M; Foßelteder, J; Prinz, F; Kapeller, A; Deutsch, A; Heitzer, E; Rinner, B; Stöger, H; Graier, WF; Pichler, M
Paraspeckle-associated protein 1 (PAP1) controls breast cancer growth by regulating and interacting with the long non-coding RNA NEAT1.
Retrain the Brain. Doctoral Day 2018. 2018; -Doctoral Day 2018; NOV 28, 2018; Graz, AUSTRIA.
[Oral Communication]
Klocker, EV; Stotz, M; Posch, F; Stojakovic, T; Stoeger, H; Kornprat, P; Gerger, A; Pichler, M
A high AST/ALT (De Ritis)-Ratio represents a poor prognostic factor in a large cohort of patients with pancreatic cancer.
OeGHO Frühjahrstagung 2018; APR 19-21, 2018; Villach, AUSTRIA. 2018.
[Poster]
Klöckl, MC; Kasparek, AK; Riedl, J; Moik ,F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer T; Stöger H; Posch, F
Estimated versus measured glomerular filtration rate to
evaluate kidney function in patients with cancer undergoing
cisplatin-based chemotherapy
Oncology Research
and Treatment . 2018; 41(Suppl4):224-224.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 )
[Poster]
Web of Science
FullText
Leithner, A; van Praag, V; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Smolle-Juttner, FM; Fiocco, M; van de Sande, M; Riedl, J; Pichler, M; Gerger, A; Szkandera, J; Stoger, H; Liegl-Atzwanger, B; Smolle, MA
Efficacy of metastasectomy on survival in patients with metachronous soft tissue sarcoma-metastasis: Results of a bi-centre study including 135 patients
ANN ONCOL. Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany. 2018; 29(S8):-43rd ESMO Congress (ESMO); OCT 19-23, 2018; Munich, GERMANY.
[Poster]
Web of Science
Mollnar, S; Pondorfer, P; Reinisch, S; Moik, F; Halm, M; Kasparek, AK; Klockl, MC; Stotz, M; Szkandera, J; Gerger, A; Vasicek, S; Weiland, T; Pichler, M; Stoger, H; Thurnher, D; Posch, F
Definitive chemoradiotherapy with or without induction chemotherapy for unresectable squamous cell carcinoma of the head & neck: a propensity-score analysis
ONCOL RES TREAT. 2018; 41: 248-248.
[Poster]
Web of Science
Muller, HD; Posch, F; Gumpoldsberger, M; Suppan, C; Hammer, R; Hauser, H; Dandachi, N; Prein, K; Stoger, H; Lax, S; Balic, M
Prognostic impact of the Residual Cancer Burden (RCB) index on recurrence-free survival of breast cancer patients recieving neoadjuvant therapy
ONCOL RES TREAT. 2018; 41: 297-298.
[Poster]
Web of Science
Smolle, MA; van Praag, V; Posch, F; Bergovec; M; Leitner, L; Friesenbichler, J; Heregger, R; Smolle-Jüttner, FM; Fiocco, M; van de Sande, M; Riedl, J; Pichler, M; Gerger, A; Szkandera, J; Stöger, H; Liegl-Atzwanger, B; Leithner, A
Effect of metastasectomy on overall-survival of patients with
metachronous metastasis of STS. A bi-centre study including
135 patients.
12th Asian Pacific Musculoskeletal Tumour Society (APMSTS) Meeting; OCT 4-7, 2018; Jaipur, INDIA. 2018.
[Poster]
Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Pichler, M; Jahn, S; Stöger, H; Bauernhofer, T
Lymphopenia impairs response to 1st-line therapy with
sunitinib and pazopanib in patients with metastatic clear-cell
renal cell carcinoma.
Oncology Research
and Treatment . 2018; 41(Suppl4):42-43.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie,; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 )
[Oral Communication]
Web of Science
FullText
Viertler, C; Stadelmeyer, E; Jahn-Kuch, D; Al-Zoughbi, W; Pabst, D; Schauer, S; Fackelmann, U; Bitsche, S; Hofmann, G; Stöger, H; Bauernhofer, T; Gerger, A; Schüler, J; Zühlsdorf, M; Höfler, G
Case Report: Patient-derived xenograft model from multi-resistant prostate cancer.
Der Pathologe. 2018; 39(5):490-490.-Herbsttagung der ÖGPath/IAP Austria; SEP 27-28, 2018; Graz, AUSTRIA.
[Poster]
Balic, M; Mueller, HD; Hammer,R; Gumpoldsberger, M; Suppan,C; Posch,F; Stoeger, H; Dandachi, N; Prein, K; Hauser, H; Lax, S;
Independent evaluation of prognostic value of residual cancer burden (RCB) score on disease free and overall survival of breast cancer patients treated with neoadjuvant systemic treatment at a single institution
Proceedings of the 40th San Antonio Breast Cancer Symposium Abstracts2View™ Portal. 2017; -SABACS; DEC 5-9 2017; San Antonio, USA.
[Poster]
FullText
Bezan, A; Pasch, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Zurl, B; Kapp, K; Stager, H; Gerger, A; Stotz, M
Clinical characterization of febrile neutropenia episodes in patients with testicular germ cell tumors.
J CLIN ONCOL. 2017; 35: -53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET; JUN 02-07, 2017; Chicago, IL.
Doi: 10.1200/JCO.2017.35.15_suppl.e16038
[Oral Communication]
Web of Science
FullText
FullText_MUG
Bitsche, S; Jahn-Kuch, D; Haslinger, S; Verebes, J; Edelsbrunner, M; Hild, R; Stöger, H; Hofmann, G
Palliative Sedation on basis of a standardized form according to the EAPC Framework for the use of sedation in palliative care – first experiences
European Journal of Palliative Care, EAPC 2017 Abstracts, Progressing Palliative Care . 2017; 1(1):704-704.-15th World Congress of the European Association for Palliative Care; MAY 18-20, 2017; Madrid, SPAIN.
[Poster]
Bjelic-Radisic, V; Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stoger, H; Pichler, A; Petru, E; Greil, R; Wette, V; Petzer, A; Sevelda, P; Egle, D; Dubsky, P; Fitzal, F; Jakesz, R; Balic, M; Frantal, S; Solkner, L; Gnant, M
Quality-of-life results from a randomized, phase-II-study of the therapeutic cancer vaccine L-BLP25 (Stimuvax (R)) in the preoperative treatment of women with primary breast cancer (ABCSG-34)
ANN ONCOL. 2017; 28: -42nd European-Society-for-Medical-Oncology Congress (ESMO); SEP 08-12, 2017; Madrid, SPAIN.
[Oral Communication]
Web of Science
Dubsky, P; Fesl, C; Singer, CF; Pfeiler, G; Kronenwett, R; Hubalek' M; Bartsch, R; Stoeger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Tea, M-KM; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Fitzal, F; Jakesz, R; Balic, M; Tinchon, C; Bago- Horvath, Z; Regitnig, P; Gnant, M, Filipits, M
The Endopredict Score Predicts Residual Cancer Burden to Noeadjuvant Chemotherapy and to Neo-Endocrine Therapy in HR+/Her2- Breast Cancer Patients from ABCSG 34
https://www.sabcs.org/2017. 2017; -San Antonio Breast Cancer Symposium; December 05-09th, 2017; San Antonio, TX, USA.
[Oral Communication]
FullText
Partl R, Bezan A, Posch F, Zurl B, Bauernhofer T, Pichler M, Szkandera J, Hutterer G, Pummer K, Kapp KS, Stöger H, Gerger A, Stotz M
Untersuchung von Risikofaktoren für die Entwicklung einer febrilen Neutropenie nach cisplatinhältiger Chemotherapie bei Patienten mit testikulären Keimzelltumoren.
Konferenzsband. 2017; -34. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik; OCT 5-6; Linz, AUSTRIA.
[Oral Communication]
Partl R, Posch F, Döller C, Riedl JM, Smolle M, Leitner L, Bergovec M, Liegl-Atzwanger B, Stotz M, Bezan A, Gerger A, Pichler M, Kapp KS, Stöger H, Leithner A, Szkandera J
Untersuchung des Benefits der adjuvanten Radiotherapie in Bezug auf Lokalkontrolle, Fernmetastasierung und Überleben bei PatientInnen mit lokalisiertem Weichteilsarkom mittels vergleichender Effektivitätsanalyse
Abstractband. 2017; -34. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik ; OCT 6-7; Linz, AUSTRIA.
[Poster]
Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J
Local Recurrence, Distant Metastasis, And Survival In Patients With Soft-Tissue Sarcoma (STS) After Curative Resection: A Multi-State Model.
Abstractbook of 18th EFORT Congress. 2017; -18th EFORT Congress; MAY 31 - JUN 2, 2017; Vienna, AUSTRIA.
[Poster]
Posch, F; Silina, K; Petrausch, U; Leibl, S; Muendlein, A; Moch, H; Siebenhuener, AR; Pestalozzi, BC; Riedl, JM; Stotz, M; Szkandera, J; Stoeger, H; Pichler, M; Stupp, R; Schraml, P; Gerger, A; Winder, T;
The maturation stage of tumoral tertiary lymphoid structures to predict recurrence risk in localized colorectal cancer.
Journal of Clinical Oncology. 2017; 35 (15_suppl): e15083-e15083.-American Society of Clinical Oncology (ASCO) Annual Meeting; JUN 2-6, 2017; Chicago, IL, USA.
FullText
Posch, Florian; Riedl, Jakob; Leitner, Lukas; Liegl-Atzwanger, Bernadette; Doeller, Carmen; Bezan, Angelika; Stotz, Michael; Pichler, Martin; Gerger, Armin; Bergovec, Marko; Stoeger, Herbert; Leithner, Andreas; Szkandera, Joanna
Benefit of adjuvant radiotherapy for local control, distant metastasis, and survival outcomes in patients with localized soft tissue sarcoma: Comparative effectiveness analysis of an observational cohort study.
Proceedings of the 30th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS), A-0001. 2017; 89--30th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS); APR 26-28, 2017; Budapest, HUNGARY.
[Oral Communication]
Schmidinger, M; Pichler, R; Bauernhofer, T; Kretz, M; Tinchon, C; Niedersuss-Beke, D; Pfleger, G; Heinrich, E; Vogl, U; Mitterberger, M; Stoger, H; Tulchiner, G; Kratochvill, F; Mraz, B; Marszalek, M
Real-world evidence data on aRCC treatment in Austria: the RELACS study
ONCOL RES TREAT. 2017; 40: 276-276.-Jahrestagung der DGHO, OeGHO, SGMO, SGH; SEP 29-OCT 3, 2017; Stuttgart, Germany.
[Oral Communication]
Web of Science
Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stoeger, H; Pichler, A; Petru, E; Greil, R; Rudas, M; Tea, MK; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Michael, G
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)
CANCER RES. 2017; 77: -San Antonio Breast Cancer Symposium; DEC 06-10, 2016; San Antonio, TX.
Doi: 10.1158/1538-7445.SABCS16-P6-10-01
[Poster]
Web of Science
FullText
FullText_MUG
Viertler, C; Stadelmeyer, E; Jahn-Kuch, D; Al-Zoughbi, W; Kashofer, K; Schauer, S; Fackelmann, U; Bitsche, S; Hofmann, G; Stöger, H; Bauernhofer, T; Schüler, J; Zühlsdorf, M; Höfler, G
Establishment of multi-resistant autopsy derived xenograft models representing progressive disease in cancer.
Der Pathologe. 2017; 38(5):487-487.-Herbsttagung der ÖGPath/IAP Austria; Sep 14-16, 2017; Velden am Wörthersee, AUSTRIA.
[Poster]
Viertler, C; Stadelmeyer, E; Jahn-Kuch, D; Al-Zoughbi, W; Kashofer, K; Schauer, S; Fackelmann, U; Thüringer, A; Bitsche, S; Hofmann, G; Stöger, H; Bauernhofer, T; Schüler, J; Zühlsdorf, M; Höfler, G
MR-PDX models for the evaluation of cancer therapies
CBmed Biomarker Conference; FEB 13, 2017; Graz, AUSTRIA. 2017.
[Poster]
Posch, F; Leitner, L; Liegl-Atzwanger, B; Wink, A; Stotz, M; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J
Benefit of adjuvant radiotherapy for local control, distant metastasis, and survival outcomes in patients with localized soft tissue sarcoma: Comparative effectiveness analysis of an observational cohort study
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); Nov 9-12; Lisbon, PORTUGAL.
[Oral Communication]
Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Friesenbichler, J; Gerger, A; Stoeger, H; Leithner, A; Szkandera, J
Conditional survival of patients with soft tissue sarcoma (STS) after curative resection
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); NOV 9-12; Lisbon, PORTUGAL.
[Poster]
Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J
Local recurrence, distant metastasis, and death in patients with soft tissue sarcoma (STS) after curative resection: A multi-state model
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); NO 9-12; Lisbon, PORTUGAL.
[Poster]
Riedl, J; Posch, F; Stotz, M; Bezan, A; Winder, T; Schaberl-Moser, R; Pichler, M; Stoeger, H; Gerger, A
Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK.
Doi: 10.1093/annonc/mdw370.107
[Poster]
Web of Science
FullText
FullText_MUG
Smolle, MA; Goldenitsch, E; Machacek, F; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J
THERAPY AND OUTCOME OF PATIENTS FOLLOWING UNPLANNED EXCISIONS IN SOFT TISSUE SARCOMA: A MULTI- CENTRE EXPERIENCE.
Abstracts of CTOS 2016; P2-P185. 2016; -CTOS 2016; NOV 9-12, 2016; Lisbon, PORTUGAL.
[Poster]
Stiegelbauer, V; Schwarzenbacher, D; Pehserl, A, Adiprasito, JB, Deutsch, A; Stöger, H; Haybaeck, J; Stotz, M; Höfler, G; Gerger, A; Pichler, M
MicroRNA196 regulates metastases formation in colorectal cancer
8th ÖGMBT Annual Meeting; SEP 12-14, 2016; Graz. 2016.
[Oral Communication]
Winder, T; Posch, F; Asamer, E; Stotz, M; Siebenhuner, A; Schlick, K; Magnes, T; Samaras, P; Szkandera, J; Clavien, PA; Neureiter, D; Greil, R; Pestalozzi, BC; Stoeger, H; Gerger, A; Egle, A; Pichler, M
An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK.
Doi: 10.1093/annonc/mdw371.77
[Poster]
Web of Science
FullText
FullText_MUG
Suppan, C; Bauernhofer, T; Eisner, F; Stöger, H; Balic, M; Schöllnast, H; Liegl-Atzwanger, B;
Efficacy of sorafenib in a patient with metastatic high grade thymic carcinoma
ÖGHO Frühjahrstagung; APR 10-12, 2014; Innsbruck, AUSTRIA. 2014.
[Poster]
Brunner, C; Jaeger, T; Suppan, C; Mueller-Holzner, E; Jasarevic, Z; Balic, M; Goebel, G; Marth, C; Stoeger, H; Samonigg, H; Hubalek,M; Lang, A;
Cardiac safety and efficacy of concomitant liposomal doxorubicin, docetaxel, and trastuzumab as neoadjuvant therapy in HER2-overexpressing breast cancer: A retrospective analysis
ASCO 2013 Annual Meeting; MAY 31-JUNE 4, 2013; Chicago, USA. 2013.
[Poster]
Gary, T; Belaj, K; Steidl, K; Pichler,M; Eisner, F; Stoeger,H; Hafner, F; Froehlich,H; Samonigg, H; Pilger,E; Brodmann, M
Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival
1.Kongress des Verbandes für österreichische Gefäßmedizin (VASCMED); Oct 18-20, 2012; Graz. 2012.
[Oral Communication]
Stöger, H
Adjuvante Chemotherapie unter 35:
zwingend indiziert?
keine. 2012; -Jubiläumskongress der Österreichischen Gesellschaft für Senologie; 27. 28. September 2012; Vienna, AUSTRIA.
[Oral Communication]
Stöger, H
Tumormarker: Wertigkeit im Alltag.
43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; 20. 22. September 2012; Graz, AUSTRIA. 2012.
[Oral Communication]
Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Heck, D; Steger, G; Jakesz, R; Singer, C; Dubsky, P; Greil, R
Preplanned subgroup analysis of ABCSG-12 suggests that benefits of adjuvant zoledronic acid (ZOL) are most pronounced in lowest estrogen environment
BREAST. 2011; 20: S69-S69.St. Gallen .
Doi: 10.1016/S0960-9776(11)70228-4
[Poster]
Web of Science
FullText
FullText_MUG
Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Poestlberger, S; Steger, G; Jakesz, R; Singer, C; Eidtmann, H; Greil, R
62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer
BONE. 2011; 48(1):S17-S17.
Doi: 10.1016/j.bone.2010.10.045
[Oral Communication]
Web of Science
FullText
FullText_MUG
Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Poestlberger, S; Steger, GG; Jakesz, R; Singer, CF; Eidtmann, H; Greil, R
ADJUVANT ENDOCRINE THERAPY, ALONE OR IN COMBINATION WITH ZOLEDRONIC ACID (ZOL), IN PREMENOPAUSAL PATIENTS (PTS) WITH ENDOCRINE-RESPONSIVE EARLY BREAST CANCER (EBC): SUBGROUP ANALYSES OF ABCSG-12
ANN ONCOL. 2010; 21: 79-79.
Web of Science
Rühlinger, D; Szkandera, J; Pichler, M; Eisner, F; Stöger, H; Bauernhofer, T;
Sorafinib as forth-line treatment in a patient with metastatic gastrointestinal stromal tumour: a case report.
MEMO Suppl 01/10; 2010; 20-20.-Frühjahrstagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10, 2010; Bregenz, AUSTRIA.
[Poster]
Steger, GG; Greil, R; Jakesz, R; Lang, A; Mlineritsch, B; Rudas, M; Marth, C; Stoeger, H; Singer, CF; Gnant, M
Independent prognostic factors for response: updated results of the ABCSG-24 study evaluating the addition of capecitabine to epirubicin-docetaxel neoadjuvant therapy for early breast cancer (EBC)
EJC SUPPL. 2010; 8(3): 60-60.
Doi: 10.1016/S1359-6349(10)70040-9
[Poster]
Web of Science
FullText
FullText_MUG
Steger, GG; Greil, R; Jakesz, R; Mlineritsch, B; Lang, A; Rudas, M; Marth, C; Stoeger, H; Singer, CF; Gnant, M
ABCSG-24: EFFICACY OF ANTHRACYCLINE- AND TAXANE-BASED NEOADJUVANT THERAPY +/- CAPECITABINE (C) IN TRIPLE-NEGATIVE EARLY BREAST CANCER (TNBC)
ANN ONCOL. 2010; 21: 79-79.
Web of Science
Knechtel, G; Stoeger, H; Szkandera, J; Dorr, K; Beham, A; Samonigg, H
Desmoid tumor treated with polychemotherapy followed by Imatinib
A case report and a review of literature
MEMO Suppl 02/09; 2009; 2: 20-20.-Frühjahrstagung 2009 der Österreichischen Gesellschaft für Hämatologie und Onkologie ; APRIL 14-16, 2009; Salzburg, AUSTRIA.
[Poster]
Stöger, H
Breast cancer in the elderly patient.
Cephalon Workshop Langenlois; February 2-3, 2008; Langenlois, Austria. 2008.
[Oral Communication]
Bauernhofer,T; Schippinger,W; Weitzer,W; Stöger, H; Samonigg,H;
Neoadjuvant therapy with liposomal doxorubicin in combination with docetaxel and trastuzumab in patients with locally advanced her2/neu positive breast cancer
Wiener Medizinische Wochenschrift2007; 157(121):9-9.-Frühjahrestagung 2007
der Österreichischen Gesellschaft für Hämatolgie und Onkologie (ÖGHO)
und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich (AHOP)
; APR 12-14, 2007; Vienna, Austria.
[Oral Communication]
Lileg, B; Weitzer, W; Stöger, H; Samonigg, H
A phase II clinical trial of Bicalutamide in patients with metastatic breast cancer expressing Androgen receptor.
2007; -ÖGHO-Jahrestagung; Apr 12-14, 2007; Vienna, Austria.
[Poster]
Stoeger, H
Epidemiologie des HER-2 positiven Mammacarcinoms.
Lapatinib Expertenmeeting Wien; 19. 9. 2007; Vienna, Austria. 2007.
[Oral Communication]
Stoeger, H
Aromatasehemmertherapie der Niedrigrisikopatientin: Upfront versus Switch.
Experts on Tour- Meeting Graz; November 28, 2007; Graz, Austria. 2007.
[Oral Communication]
Stoeger, H
Metastatic breast cancer: chemotherapy.
Joint meeting of the Slovenian and Austrian Society of Senology Graz; September 14, 2007; Graz, Austria. 2007.
[Oral Communication]
Stoeger, H
Advanced breast cancer: chemotherapy.
Joint Meeting of the Slovenian and Austrian Society of Senology Graz; 14. 9. 2007; Graz, Austria. 2007.
[Oral Communication]
Stöger, H
Die neoadjuvante Therapy des Her-2- positiven Mammacarcinoms.
ÖGHO- Meeting; May 10, 2007; Vienna, Austria. 2007.
[Oral Communication]
Stöger, H
Die interdisziplinäre Therapie von Lebertumoren.
Leberchirurgieworkshop, Universitätsklinik für Chirurgie Graz; March 5, 2007; Graz, Austria. 2007.
[Oral Communication]
Samonigg, H; Andritsch, E; Dietmaier, G; Bauernhofer, T; Andritsch, H; Zloklikovits, S; Kasparek, AK; Stoeger, H; Schaberl-Moser, R; Ploner, F
Healing by Design: the Influence of an Artistic Design on the Wellbeing of Cancer Patients-- a 10 Years Follow Up.
Journal of Clinical Oncology. 2006 ASCO Annual Meeting Proceedings Part I. (June 20 Supplement); 24(18S):-2006 ASCO Annual Meeting; JUNE 2-6, 2006; Atlanta, USA.
[Poster]
Stöger, H
Prognose im Kontext von Therapieverfahren.
Gutachtertagung des Bundesministeriums für Soziales; NOV 18, 2006; Graz, AUSTRIA. 2006.
[Oral Communication]
Weitzer, W; Bauernhofer, T; Stoeger, H; Langsenlehner, U; Lax, S; Samonigg, H
High-grade endometrial stroma sarcoma treated with aromatase inhibitor letrozole
Wiener Medizinische Wochenschrift. 156(25):9-9.-Frühjahrstagung 2006 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 27-29, 2006; Wels, AUSTRIA.
[Poster]
Zloklikovits, S; Ladinek, V; Andritsch, E; Greimel, A; Pilgram, EH; Strohscheer, I; Verebes, J; Springer-Schlegl, I; Stöger, H; Samonigg, H
Influence of the level of subjective distress of healthcare professionals on the perception of symptom intensity reported by patients with terminal cancer.
Journal of Clinical Oncology. 2006 ASCO Annual Meeting Proceedings Part I. ; 24(18S):-2006 ASCO Annual Meeting; JUNE 2-6, 2006; Atlanta, USA.
[Poster]
Eder, T; Andritsch, E; Balic, M; Stöger, H; Samonigg H
Durchgangssyndrom bei fortgeschrittener Tumorerkrankung.
Differenzialdiagnostische Überlegungen anhand eines Fallberichts.
Kongressband des 50. Ausseer Symposium 2004; -50. Ausseer Symposium; MAY 6-9, 2004; Bad Aussee, AUSTRIA.
[Oral Communication]
Samonigg, H; Hofmann, G; Bauernhofer, T; Balic, M; Stöger, H; Groiss, F; Himmler, G; Schuster, M; Rosenkaimer, F; Loibner, H
Phase if trial to explore the influence of concomitant chemotherapies on the immunogenicity of the cancer vaccine IGN101 in patients with epithelial cancers
J IMMUNOTHER 2003 26: S14-S14.
Web of Science
Samonigg, H; Hofmann, G; Bauernhofer, T; Balic,M; Stoeger, H; Himmler, G; Schuster, M; Rosenkaimer, F; Groiss,F; Loibner, H;
Phase II trial to explore the influence of concomitant chemotherapy on the immunogenicity of the cancer vaccine IGN101 in patients with epithelial cancers
Proc Am Soc Clin Oncol 2003; 22:(abstr 683): -Annual Meeting of the American Society of Clinical Oncology (ASCO); May 31-JUN 3, 2003; Chicago, Ill., USA.
[Poster]
Kuss, I; Wagner, P; Genser, B; Stöger, H; Kasparek, AK; Samonigg, H
Low dose weekly anthracycline chemotherapy for breast cancer patients with bone marrow infiltration.
ANN ONCOL 2000 11: 38-38.
Web of Science
Bauernhofer, T; Schmid, M; Stoeger, H; Kasparek, AK; Ploner, F; Kuss, I; Gilli, R; Lanzer, H; Samonigg, H
Sequential dose intensive chemotherapy with cyclophosphamide and carboplatin (CC) with peripheral blood progenitor cell (PBPC) support in metastatic breast cancer patients.
BONE MARROW TRANSPLANT 1999 23: S37-S37.
Web of Science
Kapp, KS; Geyer, E; Gebhart, FH; Oechs, AC, Berger, A; Hebenstreit, J; Stoeger, H
Evaluation of sphincter fundtion after external beam irradiation and IR-192 high-dose rate (HDR) brachytherapie +/- chemotherapy in patients with carcinoma of the anal canal.
Proceedidngs of the 41st Annual ASTRO Meeting, Int J Radiat Oncol Biol Phys 1999; 45(3):339--41st Annual Meeting of the American Society for Therapeutic Radioonkologie and Onkologie; OKT 31 - NOV 4, 1999; San Antonio, Texas, USA.
[Poster]
Kapp, KS; Geyer, E; Gebhart, FH, Oechs, AC; Berger, A; Hebenstreit, J; Stöger, H
Experience with split-course external beam irradiation +/- and integrated IR-192 high-dose rate brachytherapiy in the treatment of primary carcinomas of the anal canal.
Proceedings of the 41st Annual Scientific Meeting of ASTRO1999; -41st Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO); OKT 31 - NOV 4, 1999; San Antonio, Texas, USA.
[Poster]
Derstvenscheg, E; Stöger, H; Stranzl, H; Bauernhofer, T; Ploner, F; Samonigg, H
Das männl. Mammakarzinom- ein Bericht über 43 Patienten
Acta Chirurgica Austriaca, 28 (125), 1996, p 131996; 28(125):13-13.-Senologiekongress; 17.-19. Oktober 1996; Graz, Österreich.
[Poster]
SAMONIGG, H; WILDERSTRUSCHNIG, M; KUSS, I; PLOT, R; STOGER, H; SCHMID, M; BAUERNHOFER, T; TIRAN, A; HAVELEC, L; LOIBNER, H
IMMUNIZATION WITH ANTIIDIOTYPE VACCINE SCV-106 PROLONGS SURVIVAL-TIME OF CANCER-PATIENTS WITH METASTATIC COLORECTAL-CANCER - A RANDOMIZED DOUBLE-BLIND CLINICAL-TRIAL
EUR J CANCER 1995 31A: 45-45.
Web of Science